BG
EXAS

Bellevue Group’s Exact Sciences EXAS Stock Holding History

Bellevue Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,062
Closed -$1.63M – 169
2025
Q4 		$1.63M Sell
16,062
-236,639
-94% -$19M 0.03% 102
2025
Q3 		$13.8M Sell
252,701
-31,500
-11% -$1.57M 0.29% 58
2025
Q2 		$15.1M Sell
284,201
-294,873
-51% -$15M 0.33% 54
2025
Q1 		$25.1M Sell
579,074
-114,982
-17% -$5.82M 0.56% 42
2024
Q4 		$39M Sell
694,056
-755,409
-52% -$47M 0.75% 28
2024
Q3 		$98.7M Buy
1,449,465
+290,585
+25% +$16.4M 1.6% 18
2024
Q2 		$49M Buy
1,158,880
+20,354
+2% +$1.12M 0.8% 29
2024
Q1 		$78.6M Buy
1,138,526
+90,740
+9% +$5.74M 1.2% 23
2023
Q4 		$77.5M Sell
1,047,786
-72,033
-6% -$4.72M 1.19% 24
2023
Q3 		$76.4M Buy
1,119,819
+113,047
+11% +$9.59M 1.23% 21
2023
Q2 		$94.5M Sell
1,006,772
-218,270
-18% -$17M 1.35% 24
2023
Q1 		$83.1M Sell
1,225,042
-86,973
-7% -$5.59M 1.21% 27
2022
Q4 		$65M Buy
1,312,015
+182,362
+16% +$7.45M 0.86% 35
2022
Q3 		$36.7M Buy
1,129,653
+371,630
+49% +$15.3M 0.53% 56
2022
Q2 		$29.9M Buy
758,023
+38,720
+5% +$2.07M 0.42% 65
2022
Q1 		$50.3M Buy
719,303
+76,721
+12% +$5.61M 0.58% 57
2021
Q4 		$50M Buy
642,582
+213,309
+50% +$18.8M 0.52% 65
2021
Q3 		$41M Buy
429,273
+153,600
+56% +$16.2M 0.42% 76
2021
Q2 		$34.3M Buy
275,673
+57,533
+26% +$6.87M 0.33% 88
2021
Q1 		$28.7M Buy
218,140
+23,140
+12% +$3.17M 0.3% 91
2020
Q4 		$25.8M Sell
195,000
-109,490
-36% -$13.2M 0.3% 86
2020
Q3 		$31M Buy
+304,490
New +$26.3M 0.43% 63

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Bellevue Group's EXAS Position: Q1 2026 in Review

Bellevue Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 16,062 shares — an estimated $1.63M sold.

Bellevue Group first reported a position in EXAS in Q3 2020 and held it in 22 quarters. The position peaked at $98.7M in Q3 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Bellevue Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Bellevue Group sold 16,062 Exact Sciences shares in Q1 2026, an estimated $1.63M.
  • Bellevue Group first reported a position in Exact Sciences in Q3 2020 and held it in 22 quarters.
  • Bellevue Group's Exact Sciences position peaked at $98.7M in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Bellevue Group's 13F filing for Q1 2026, filed 15 May 2026.